Welcome to the e-CCO Library!

P433: Sex-based differences in response to tumor necrosis factor inhibitor induction therapy for ulcerative colitis: a pooled analysis of individual patient-level clinical trials data
Year: 2021
Source: ECCO'21 Virtual
Authors: Agrawal, M.(1);Petralia, F.(2);Tepler, A.(3);Durbin, L.(4);Reinisch, W.(5);Colombel, J.F.(1);Shah, S.(6,7);
Created: Wednesday, 2 June 2021, 4:12 PM
P434 Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Chaparro1, A. Garre1, M. Iborra2, M. Barreiro-de Acosta3, M.J. Casanova1, L. De Castro4, A. Fernández-Clotet5, J. Hinojosa6, M. Boscá-Watts7, D. Busquets8, A. López-García9, R. Lorente10, N. Manceñido11, T. Martínez12, D. Monfort13, J.L. Pérez-Calle14, A. Villoria15, T. Angueira16, F. Bermejo17, A.Y. Carbajo18, D. Carpio19, C. González-Muñoza20, F. Gomollón21, J.M. Huguet22, M. Rivero23, E. Iglesias-Flores24, M. Sierra25, L. Hernández-Villalba26, E. Domènech27, J.P. Gisbert1

Created: Thursday, 30 January 2020, 10:12 AM
P434: Close rectal versus total mesorectal excision in patients with inflammatory bowel disease undergoing proctocolectomy or completion proctectomy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. de Groof*, O. van Ruler, P. Tanis, W. Bemelman, C. Buskens

Created: Friday, 22 February 2019, 9:49 AM
P434: Factors associated with medical and psycosocioeconomic changes in IBD during the COVID-19 pandemic and post-pandemic period
Year: 2021
Source: ECCO'21 Virtual
Authors: Hu, S.(1);Wang, X.(1);Shen, B.(2);Yu, Q.(1);Zheng, J.J.(3);Chen, Y.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P434: Joint Inflammatory Bowel Disease–Obstetric clinics: outcomes in 95 pregnancies at a tertiary centre over a 3-year period
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Chew T.S.*1, Carmichael M.S.1, Hoare T.W.2, Waugh J.3, Gunn M.C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P434: Remission induction in corticosteroid naive children and adolescents with active ulcerative colitis by adsorptive leucocytapheresis after failure of first-line medications: Results from routine clinical practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Tanaka*, M. Akagi, H. Goishi, T. Iiboshi, T. Kajihara, T. Miura

Created: Thursday, 21 February 2019, 9:14 AM
P434: Surgery management of Crohn's disease in children: our experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Pujol Muncunill*1, J. González Pérez1, L. Saura García2, A. I. Pascual Pérez1, V. Vila Miravet1, X. Tarrado Castellarnau2, J. Martin de Carpi1

Created: Friday, 22 February 2019, 9:41 AM
P434: The PROPER study: interim analysis of a Pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Dignass, A.U.(1);Gisbert, J.P.(2);Bossa, F.(3);Freudensprung, U.(4);Addison, J.(5);
Created: Friday, 11 February 2022, 3:52 PM
P434: Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ghosh, S.(1)*;Feagan, B.(2);Parra, R.S.(3);Lopes, S.(4);Steinlauf, A.(5);Kakuta, Y.(6);Joshi, N.(7);Lee, W.J.(7);Remple, V.(7);Lacerda, A.P.(7);Zhou, Q.(7);Xuan, S.(7);Louis, E.(8);
Created: Friday, 14 July 2023, 11:05 AM
P435 Real-world clinical outcomes after elective discontinuation of first-use biologics in IBD patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

U.N. Shivaji1, A. Bazarova2, T. Critchlow3, O.M. Nardone4, S.C. Smith4, M. Love3, J. Davis3, S. Ghosh1, M. Iacucci1

Created: Thursday, 30 January 2020, 10:12 AM
P435: Effectiveness of therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease patients. Systematic review and meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Petryszyn*, L. Dybalski, K. Gola

Created: Thursday, 21 February 2019, 9:14 AM
P435: High rate of vitamin deficiencies in patients after total proctocolectomy and pouch surgery- results from a prospective cohort
Year: 2022
Source: ECCO'22
Authors: Elial-Fatal, S.(1);Pfeffer-Gik, T.(1,2);Raykhel, B.(1);Friedenberg, A.(1);Margolis, L.(1);Barkan, R.(1);Ollech, J.(1,2);Yanai, H.(1,2);Wasserberg, N.(2,3);White, I.(2,3);Dotan, I.(1,2);Godny, L.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P435: Liver injury associated with anti-tumour necrosis factor therapy in paediatric irritable bowel disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Ricciuto*, B. M. Kamath, T. Walters, P. Church, S. C. Ling, K. Frost, A. Griffiths

Created: Friday, 22 February 2019, 9:49 AM
P435: Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. D’Haens*1, E. V. Loftus Jr2, P. D. R. Higgins3, J. Panes4, R. Panaccione5, W. Zhou6, F. Cataldi6, W-J. Lee6, B. Huang6, W. Xie6, S. Vermeire7

Created: Friday, 22 February 2019, 9:41 AM
P435: The impact of perianal fistula in Crohn’s disease on quality of life: results of a patient survey conducted in Europe
Year: 2021
Source: ECCO'21 Virtual
Authors: Spinelli, A.(1,2);Yanai, H.(3);Lönnfors, S.(4);Girardi, P.(5);Milicevic, S.(6);Carvello, M.(1);Maroli, A.(1);Avedano , L.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P435: The mean corpuscular volume flow – prognostic value for inflammatory bowel disease under thiopurine treatment
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Roseira J.*1, Tavares de Sousa H.1, Marreiros A.2, Queiros P.1, Vaz A.M.1, Gago T.1, Contente L.1, Guerreiro H.1

Created: Wednesday, 20 February 2019, 10:36 AM
P436 Evaluation of targeted vitamin D supplementation regimen in postoperative patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. LI, L. Zheng, D. Yao, Z. Zhou, B. Liu, Y. Huang, Y. Duan

Created: Thursday, 30 January 2020, 10:12 AM
P436: Adalimumab dose escalation is effective and well tolerated in Crohn’s disease patients with secondary loss of response to adalimumab
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Duveau*, M. Nachury, M. Boualit, R. Gerard, J. Branche, V. Maunoury, P. Desreumaux, B. Pariente

Created: Friday, 22 February 2019, 9:49 AM
P436: Darvadstrocel treatment outcomes in Crohn’s disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Panés*1, D. García-Olmo2, D. Lindner3, I. Tagarro García4, C. Agboton3

Created: Friday, 22 February 2019, 9:41 AM